- Market Realist•yesterday
Sanofi has reorganized its diabetes and cardiovascular franchise, making it one of the largest revenue contributors to the pharmaceutical business.
- The Wall Street Journal•yesterday
The drug industry has had multiple expensive failures trying to treat Alzheimer’s disease, yet the big potential payoff keeps it searching.
- Motley Fool•3 days ago
Which healthcare stock wins in a head-to-head match-up between Eli Lilly and Johnson & Johnson?
LLY : Summary for Eli Lilly and Company - Yahoo Finance
Eli Lilly and Company (LLY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||31.18|
|Dividend & Yield||2.08 (2.59%)|
|1y Target Est||N/A|